Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome

To perform phenotype and genotype characterization in myoclonus-dystonia patients and to validate clinical rating tools. Two movement disorders experts rated patients with the Burke-Fahn-Marsden and Unified-Myoclonus rating scales using a video-recording protocol. Clinimetric analysis was performed....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Parkinsonism & related disorders 2020-11, Vol.80, p.165-174
Hauptverfasser: Vanegas, Maria I., Marcé-Grau, Anna, Martí-Sánchez, Laura, Mellid, Sara, Baide-Mairena, Heidy, Correa-Vela, Marta, Cazurro, Anna, Rodríguez, Carla, Toledo, Laura, Fernández-Ramos, Joaquín Alejandro, Pons, Roser, Aguilera-Albesa, Sergio, Martí, Maria José, Eiris, Jesús, Iglesias, Gema, De Fabregues, Oriol, Maqueda, Elena, Garriz-Luis, Maite, Madruga, Marcos, Espinós, Carmen, Macaya, Alfons, Cabrera, José Carlos, Pérez-Dueñas, Belén
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 174
container_issue
container_start_page 165
container_title Parkinsonism & related disorders
container_volume 80
creator Vanegas, Maria I.
Marcé-Grau, Anna
Martí-Sánchez, Laura
Mellid, Sara
Baide-Mairena, Heidy
Correa-Vela, Marta
Cazurro, Anna
Rodríguez, Carla
Toledo, Laura
Fernández-Ramos, Joaquín Alejandro
Pons, Roser
Aguilera-Albesa, Sergio
Martí, Maria José
Eiris, Jesús
Iglesias, Gema
De Fabregues, Oriol
Maqueda, Elena
Garriz-Luis, Maite
Madruga, Marcos
Espinós, Carmen
Macaya, Alfons
Cabrera, José Carlos
Pérez-Dueñas, Belén
description To perform phenotype and genotype characterization in myoclonus-dystonia patients and to validate clinical rating tools. Two movement disorders experts rated patients with the Burke-Fahn-Marsden and Unified-Myoclonus rating scales using a video-recording protocol. Clinimetric analysis was performed. SGCE mutations were screened by Sanger sequencing and multiplex ligation-dependent probe amplification. 48 patients were included and 43/48 rated. Mean age at assessment was 12.9±10.5 years (range 3–51) and 88% were ≤18 years of age. Myoclonus was a universal sign with a rostro-caudal severity-gradient. Myoclonus increased in severity and spread to lower limbs during action tests. Stimulus-evoked myoclonus was observed in 86.8% cases. Dystonia was common but mild. It had a focal distribution and was action-induced, causing writer's cramp (69%) and gait dystonia (34%). The severity of both myoclonus and dystonia had a strong impact on hand writing and walking difficulties. The Unified Myoclonus Rating scale showed the best clinimetric properties for the questionnaire, action myoclonus and functional subscales, and exceeded the Burke-Fahn-Marsden scale in its utility in assessing functional impairment in MDS patients. Twenty-one different SGCE mutations were identified in 45/48 patients, eleven being novel (most prevalent p. Val187*, founder mutation in Canary Islands). This study quantifies the severity of the motor phenotype in SGCE-myoclonus dystonia syndrome, with a special focus on children, and identifies disabilities in gross and fine motor tasks that are essential for childhood development. Our results contribute to the knowledge of SGCE-related MDS in the early stage of evolution, where disease-modifying therapies could be initiated in order to prevent long-term social and physical burdens. •In children with MDS-SGCE, myoclonus was a universal sign.•Myoclonus and dystonia had a strong and independent impact on gross and fine motor tasks.•The UMRS exceeded the BFMDRS in its utility in assessing functional impairment.•A specific questionnaire and motor scale for pre-school children should be designed.
doi_str_mv 10.1016/j.parkreldis.2020.09.023
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2449178866</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1353802020307379</els_id><sourcerecordid>2449178866</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-30dce626c9df70aad077065840418574fe053d89d21e4b93eece5df892f4f20d3</originalsourceid><addsrcrecordid>eNqFkE1PwzAMhiMEYjD4C6hHLi3OR9v0CGMMpEkcgHPUJS7LaJuSdEj993TagCMnW_Lz2vJDSEQhoUCzm03Slf7DY21sSBgwSKBIgPEjckZlzuOUsux47HnKYzmOJ-Q8hA0A5CnwUzLhHBgTPDsjs3usbYtlb9v3qF9j1Lje-ahbY-v6ocPIVdHLYjaPm8Hp2rXbEJkh9K61ZRSG1njX4AU5qco64OWhTsnbw_x19hgvnxdPs9tlrHku-piD0ZixTBemyqEsDeQ5ZKkUIKhMc1EhpNzIwjCKYlVwRI2pqWTBKlExMHxKrvd7O-8-txh61digsa7LFt02KCZEQXMps2xE5R7V3oXgsVKdt03pB0VB7RSqjfpTqHYKFRRqVDhGrw5XtqsGzW_wx9kI3O0BHH_9suhV0BZbjcZ61L0yzv5_5RsCS4e-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2449178866</pqid></control><display><type>article</type><title>Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome</title><source>Elsevier ScienceDirect Journals</source><creator>Vanegas, Maria I. ; Marcé-Grau, Anna ; Martí-Sánchez, Laura ; Mellid, Sara ; Baide-Mairena, Heidy ; Correa-Vela, Marta ; Cazurro, Anna ; Rodríguez, Carla ; Toledo, Laura ; Fernández-Ramos, Joaquín Alejandro ; Pons, Roser ; Aguilera-Albesa, Sergio ; Martí, Maria José ; Eiris, Jesús ; Iglesias, Gema ; De Fabregues, Oriol ; Maqueda, Elena ; Garriz-Luis, Maite ; Madruga, Marcos ; Espinós, Carmen ; Macaya, Alfons ; Cabrera, José Carlos ; Pérez-Dueñas, Belén</creator><creatorcontrib>Vanegas, Maria I. ; Marcé-Grau, Anna ; Martí-Sánchez, Laura ; Mellid, Sara ; Baide-Mairena, Heidy ; Correa-Vela, Marta ; Cazurro, Anna ; Rodríguez, Carla ; Toledo, Laura ; Fernández-Ramos, Joaquín Alejandro ; Pons, Roser ; Aguilera-Albesa, Sergio ; Martí, Maria José ; Eiris, Jesús ; Iglesias, Gema ; De Fabregues, Oriol ; Maqueda, Elena ; Garriz-Luis, Maite ; Madruga, Marcos ; Espinós, Carmen ; Macaya, Alfons ; Cabrera, José Carlos ; Pérez-Dueñas, Belén</creatorcontrib><description>To perform phenotype and genotype characterization in myoclonus-dystonia patients and to validate clinical rating tools. Two movement disorders experts rated patients with the Burke-Fahn-Marsden and Unified-Myoclonus rating scales using a video-recording protocol. Clinimetric analysis was performed. SGCE mutations were screened by Sanger sequencing and multiplex ligation-dependent probe amplification. 48 patients were included and 43/48 rated. Mean age at assessment was 12.9±10.5 years (range 3–51) and 88% were ≤18 years of age. Myoclonus was a universal sign with a rostro-caudal severity-gradient. Myoclonus increased in severity and spread to lower limbs during action tests. Stimulus-evoked myoclonus was observed in 86.8% cases. Dystonia was common but mild. It had a focal distribution and was action-induced, causing writer's cramp (69%) and gait dystonia (34%). The severity of both myoclonus and dystonia had a strong impact on hand writing and walking difficulties. The Unified Myoclonus Rating scale showed the best clinimetric properties for the questionnaire, action myoclonus and functional subscales, and exceeded the Burke-Fahn-Marsden scale in its utility in assessing functional impairment in MDS patients. Twenty-one different SGCE mutations were identified in 45/48 patients, eleven being novel (most prevalent p. Val187*, founder mutation in Canary Islands). This study quantifies the severity of the motor phenotype in SGCE-myoclonus dystonia syndrome, with a special focus on children, and identifies disabilities in gross and fine motor tasks that are essential for childhood development. Our results contribute to the knowledge of SGCE-related MDS in the early stage of evolution, where disease-modifying therapies could be initiated in order to prevent long-term social and physical burdens. •In children with MDS-SGCE, myoclonus was a universal sign.•Myoclonus and dystonia had a strong and independent impact on gross and fine motor tasks.•The UMRS exceeded the BFMDRS in its utility in assessing functional impairment.•A specific questionnaire and motor scale for pre-school children should be designed.</description><identifier>ISSN: 1353-8020</identifier><identifier>EISSN: 1873-5126</identifier><identifier>DOI: 10.1016/j.parkreldis.2020.09.023</identifier><identifier>PMID: 33022436</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Parkinsonism &amp; related disorders, 2020-11, Vol.80, p.165-174</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-30dce626c9df70aad077065840418574fe053d89d21e4b93eece5df892f4f20d3</citedby><cites>FETCH-LOGICAL-c374t-30dce626c9df70aad077065840418574fe053d89d21e4b93eece5df892f4f20d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1353802020307379$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33022436$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vanegas, Maria I.</creatorcontrib><creatorcontrib>Marcé-Grau, Anna</creatorcontrib><creatorcontrib>Martí-Sánchez, Laura</creatorcontrib><creatorcontrib>Mellid, Sara</creatorcontrib><creatorcontrib>Baide-Mairena, Heidy</creatorcontrib><creatorcontrib>Correa-Vela, Marta</creatorcontrib><creatorcontrib>Cazurro, Anna</creatorcontrib><creatorcontrib>Rodríguez, Carla</creatorcontrib><creatorcontrib>Toledo, Laura</creatorcontrib><creatorcontrib>Fernández-Ramos, Joaquín Alejandro</creatorcontrib><creatorcontrib>Pons, Roser</creatorcontrib><creatorcontrib>Aguilera-Albesa, Sergio</creatorcontrib><creatorcontrib>Martí, Maria José</creatorcontrib><creatorcontrib>Eiris, Jesús</creatorcontrib><creatorcontrib>Iglesias, Gema</creatorcontrib><creatorcontrib>De Fabregues, Oriol</creatorcontrib><creatorcontrib>Maqueda, Elena</creatorcontrib><creatorcontrib>Garriz-Luis, Maite</creatorcontrib><creatorcontrib>Madruga, Marcos</creatorcontrib><creatorcontrib>Espinós, Carmen</creatorcontrib><creatorcontrib>Macaya, Alfons</creatorcontrib><creatorcontrib>Cabrera, José Carlos</creatorcontrib><creatorcontrib>Pérez-Dueñas, Belén</creatorcontrib><title>Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome</title><title>Parkinsonism &amp; related disorders</title><addtitle>Parkinsonism Relat Disord</addtitle><description>To perform phenotype and genotype characterization in myoclonus-dystonia patients and to validate clinical rating tools. Two movement disorders experts rated patients with the Burke-Fahn-Marsden and Unified-Myoclonus rating scales using a video-recording protocol. Clinimetric analysis was performed. SGCE mutations were screened by Sanger sequencing and multiplex ligation-dependent probe amplification. 48 patients were included and 43/48 rated. Mean age at assessment was 12.9±10.5 years (range 3–51) and 88% were ≤18 years of age. Myoclonus was a universal sign with a rostro-caudal severity-gradient. Myoclonus increased in severity and spread to lower limbs during action tests. Stimulus-evoked myoclonus was observed in 86.8% cases. Dystonia was common but mild. It had a focal distribution and was action-induced, causing writer's cramp (69%) and gait dystonia (34%). The severity of both myoclonus and dystonia had a strong impact on hand writing and walking difficulties. The Unified Myoclonus Rating scale showed the best clinimetric properties for the questionnaire, action myoclonus and functional subscales, and exceeded the Burke-Fahn-Marsden scale in its utility in assessing functional impairment in MDS patients. Twenty-one different SGCE mutations were identified in 45/48 patients, eleven being novel (most prevalent p. Val187*, founder mutation in Canary Islands). This study quantifies the severity of the motor phenotype in SGCE-myoclonus dystonia syndrome, with a special focus on children, and identifies disabilities in gross and fine motor tasks that are essential for childhood development. Our results contribute to the knowledge of SGCE-related MDS in the early stage of evolution, where disease-modifying therapies could be initiated in order to prevent long-term social and physical burdens. •In children with MDS-SGCE, myoclonus was a universal sign.•Myoclonus and dystonia had a strong and independent impact on gross and fine motor tasks.•The UMRS exceeded the BFMDRS in its utility in assessing functional impairment.•A specific questionnaire and motor scale for pre-school children should be designed.</description><issn>1353-8020</issn><issn>1873-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkE1PwzAMhiMEYjD4C6hHLi3OR9v0CGMMpEkcgHPUJS7LaJuSdEj993TagCMnW_Lz2vJDSEQhoUCzm03Slf7DY21sSBgwSKBIgPEjckZlzuOUsux47HnKYzmOJ-Q8hA0A5CnwUzLhHBgTPDsjs3usbYtlb9v3qF9j1Lje-ahbY-v6ocPIVdHLYjaPm8Hp2rXbEJkh9K61ZRSG1njX4AU5qco64OWhTsnbw_x19hgvnxdPs9tlrHku-piD0ZixTBemyqEsDeQ5ZKkUIKhMc1EhpNzIwjCKYlVwRI2pqWTBKlExMHxKrvd7O-8-txh61digsa7LFt02KCZEQXMps2xE5R7V3oXgsVKdt03pB0VB7RSqjfpTqHYKFRRqVDhGrw5XtqsGzW_wx9kI3O0BHH_9suhV0BZbjcZ61L0yzv5_5RsCS4e-</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Vanegas, Maria I.</creator><creator>Marcé-Grau, Anna</creator><creator>Martí-Sánchez, Laura</creator><creator>Mellid, Sara</creator><creator>Baide-Mairena, Heidy</creator><creator>Correa-Vela, Marta</creator><creator>Cazurro, Anna</creator><creator>Rodríguez, Carla</creator><creator>Toledo, Laura</creator><creator>Fernández-Ramos, Joaquín Alejandro</creator><creator>Pons, Roser</creator><creator>Aguilera-Albesa, Sergio</creator><creator>Martí, Maria José</creator><creator>Eiris, Jesús</creator><creator>Iglesias, Gema</creator><creator>De Fabregues, Oriol</creator><creator>Maqueda, Elena</creator><creator>Garriz-Luis, Maite</creator><creator>Madruga, Marcos</creator><creator>Espinós, Carmen</creator><creator>Macaya, Alfons</creator><creator>Cabrera, José Carlos</creator><creator>Pérez-Dueñas, Belén</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202011</creationdate><title>Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome</title><author>Vanegas, Maria I. ; Marcé-Grau, Anna ; Martí-Sánchez, Laura ; Mellid, Sara ; Baide-Mairena, Heidy ; Correa-Vela, Marta ; Cazurro, Anna ; Rodríguez, Carla ; Toledo, Laura ; Fernández-Ramos, Joaquín Alejandro ; Pons, Roser ; Aguilera-Albesa, Sergio ; Martí, Maria José ; Eiris, Jesús ; Iglesias, Gema ; De Fabregues, Oriol ; Maqueda, Elena ; Garriz-Luis, Maite ; Madruga, Marcos ; Espinós, Carmen ; Macaya, Alfons ; Cabrera, José Carlos ; Pérez-Dueñas, Belén</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-30dce626c9df70aad077065840418574fe053d89d21e4b93eece5df892f4f20d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vanegas, Maria I.</creatorcontrib><creatorcontrib>Marcé-Grau, Anna</creatorcontrib><creatorcontrib>Martí-Sánchez, Laura</creatorcontrib><creatorcontrib>Mellid, Sara</creatorcontrib><creatorcontrib>Baide-Mairena, Heidy</creatorcontrib><creatorcontrib>Correa-Vela, Marta</creatorcontrib><creatorcontrib>Cazurro, Anna</creatorcontrib><creatorcontrib>Rodríguez, Carla</creatorcontrib><creatorcontrib>Toledo, Laura</creatorcontrib><creatorcontrib>Fernández-Ramos, Joaquín Alejandro</creatorcontrib><creatorcontrib>Pons, Roser</creatorcontrib><creatorcontrib>Aguilera-Albesa, Sergio</creatorcontrib><creatorcontrib>Martí, Maria José</creatorcontrib><creatorcontrib>Eiris, Jesús</creatorcontrib><creatorcontrib>Iglesias, Gema</creatorcontrib><creatorcontrib>De Fabregues, Oriol</creatorcontrib><creatorcontrib>Maqueda, Elena</creatorcontrib><creatorcontrib>Garriz-Luis, Maite</creatorcontrib><creatorcontrib>Madruga, Marcos</creatorcontrib><creatorcontrib>Espinós, Carmen</creatorcontrib><creatorcontrib>Macaya, Alfons</creatorcontrib><creatorcontrib>Cabrera, José Carlos</creatorcontrib><creatorcontrib>Pérez-Dueñas, Belén</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Parkinsonism &amp; related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vanegas, Maria I.</au><au>Marcé-Grau, Anna</au><au>Martí-Sánchez, Laura</au><au>Mellid, Sara</au><au>Baide-Mairena, Heidy</au><au>Correa-Vela, Marta</au><au>Cazurro, Anna</au><au>Rodríguez, Carla</au><au>Toledo, Laura</au><au>Fernández-Ramos, Joaquín Alejandro</au><au>Pons, Roser</au><au>Aguilera-Albesa, Sergio</au><au>Martí, Maria José</au><au>Eiris, Jesús</au><au>Iglesias, Gema</au><au>De Fabregues, Oriol</au><au>Maqueda, Elena</au><au>Garriz-Luis, Maite</au><au>Madruga, Marcos</au><au>Espinós, Carmen</au><au>Macaya, Alfons</au><au>Cabrera, José Carlos</au><au>Pérez-Dueñas, Belén</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome</atitle><jtitle>Parkinsonism &amp; related disorders</jtitle><addtitle>Parkinsonism Relat Disord</addtitle><date>2020-11</date><risdate>2020</risdate><volume>80</volume><spage>165</spage><epage>174</epage><pages>165-174</pages><issn>1353-8020</issn><eissn>1873-5126</eissn><abstract>To perform phenotype and genotype characterization in myoclonus-dystonia patients and to validate clinical rating tools. Two movement disorders experts rated patients with the Burke-Fahn-Marsden and Unified-Myoclonus rating scales using a video-recording protocol. Clinimetric analysis was performed. SGCE mutations were screened by Sanger sequencing and multiplex ligation-dependent probe amplification. 48 patients were included and 43/48 rated. Mean age at assessment was 12.9±10.5 years (range 3–51) and 88% were ≤18 years of age. Myoclonus was a universal sign with a rostro-caudal severity-gradient. Myoclonus increased in severity and spread to lower limbs during action tests. Stimulus-evoked myoclonus was observed in 86.8% cases. Dystonia was common but mild. It had a focal distribution and was action-induced, causing writer's cramp (69%) and gait dystonia (34%). The severity of both myoclonus and dystonia had a strong impact on hand writing and walking difficulties. The Unified Myoclonus Rating scale showed the best clinimetric properties for the questionnaire, action myoclonus and functional subscales, and exceeded the Burke-Fahn-Marsden scale in its utility in assessing functional impairment in MDS patients. Twenty-one different SGCE mutations were identified in 45/48 patients, eleven being novel (most prevalent p. Val187*, founder mutation in Canary Islands). This study quantifies the severity of the motor phenotype in SGCE-myoclonus dystonia syndrome, with a special focus on children, and identifies disabilities in gross and fine motor tasks that are essential for childhood development. Our results contribute to the knowledge of SGCE-related MDS in the early stage of evolution, where disease-modifying therapies could be initiated in order to prevent long-term social and physical burdens. •In children with MDS-SGCE, myoclonus was a universal sign.•Myoclonus and dystonia had a strong and independent impact on gross and fine motor tasks.•The UMRS exceeded the BFMDRS in its utility in assessing functional impairment.•A specific questionnaire and motor scale for pre-school children should be designed.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33022436</pmid><doi>10.1016/j.parkreldis.2020.09.023</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1353-8020
ispartof Parkinsonism & related disorders, 2020-11, Vol.80, p.165-174
issn 1353-8020
1873-5126
language eng
recordid cdi_proquest_miscellaneous_2449178866
source Elsevier ScienceDirect Journals
title Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T04%3A59%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Delineating%20the%20motor%20phenotype%20of%20SGCE-myoclonus%20dystonia%20syndrome&rft.jtitle=Parkinsonism%20&%20related%20disorders&rft.au=Vanegas,%20Maria%20I.&rft.date=2020-11&rft.volume=80&rft.spage=165&rft.epage=174&rft.pages=165-174&rft.issn=1353-8020&rft.eissn=1873-5126&rft_id=info:doi/10.1016/j.parkreldis.2020.09.023&rft_dat=%3Cproquest_cross%3E2449178866%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2449178866&rft_id=info:pmid/33022436&rft_els_id=S1353802020307379&rfr_iscdi=true